Zoekresultaten - 8 results

Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.

of comorbidities and high care dependency predicted SARS-CoV-2 seronegativity in NHR. CONCLUSION: These findings highlight the need for further monitoring of SARS-CoV-2 immunity upon vaccination in the ...

Humoral and cellular immune responses against SARS-CoV-2 after third dose BNT162b2 following double-dose vaccination with BNT162b2 versus ChAdOx1 in cancer patients.

healthy) received a third dose of BNT162 b2 (230 homologous vs 212 heterologous). Vaccine-induced adverse events (AE) were captured up to 7 days after vaccination. Humoral immunity was assessed by SARS-CoV-2 ...

Antibody titres before and after a third dose of the SARS-CoV-2 BNT162b2 vaccine in patients with cancer.

Viral Biomarkers BNT162 Vaccine COVID-19 Vaccines Humans Immunity, Humoral Immunization Schedule Immunization, Secondary Immunogenicity, Vaccine Neoplasms Prospective Studies Risk Factors Time Factors ...

Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.

5 (2021) Keywords: Antineoplastic Agents BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans Immunity, Humoral Neoplasms Prospective Studies RNA, Messenger SARS-CoV-2 Vaccination Abstract: BACKGROUND: Cancer ...

Vaccine preventable bacterial diseases in Belgium: monitoring of general population immunity and pregnancy vaccination strategies

Publication Type: Dissertation Authors: Raïssa Nadège Caboré Source: VUB, Brussels, Belgium, p.183 (2017) Accession Number: NA Keywords: bacterial diseases Belgium general population immunity ...

Immunogenicity and protective efficacy of tuberculosis subunit vaccines expressing PPE44 (Rv2770c).

Immunity, Cellular Immunotherapy, Adoptive mice Mice, Inbred Strains Molecular Sequence Data Mycobacterium tuberculosis Phylogeny RNA, Messenger Tuberculosis Vaccines Tuberculosis, Pulmonary Vaccines, DNA ...

Induction of immunity by DNA vaccination: application to influenza and tuberculosis.

Immunity, Cellular Influenza A virus Influenza Vaccines Lymphocyte Activation mice Mice, Inbred BALB C Mice, Inbred C57BL Mycobacterium tuberculosis Nucleoproteins RNA-Binding Proteins Spleen T-Lymphocytes, ...

Immunogenicity and protective efficacy of a tuberculosis DNA vaccine.

Bacterial BCG Vaccine Cytokines Disease Models, Animal DNA, Bacterial Immunity, Cellular mice Mice, Inbred BALB C Mice, Inbred C57BL Mycobacterium tuberculosis T-Lymphocytes Tuberculosis Tumor Cells, Cultured ...

QR code

QR code for this page URL